189 Levetiracetam as the first line treatment for neonatal seizures - a systematic review and meta-analysis
Saved in:
Main Authors: | Viraraghavan Vadakkencherry Ramaswamy (Author), Robert Hooper (Author), Rachael Wahid (Author), Prakash Satodia (Author), Adarsh Bhulani (Author) |
---|---|
Format: | Book |
Published: |
BMJ Publishing Group,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Levetiracetam as the First-line Antiepileptic in Neonatal Seizures
by: Hari Prasath Ramachandran, et al.
Published: (2020) -
A Comparative Study of Levetiracetam and Phenobarbital for Neonatal Seizures as a First Line Treatment
by: Nagwa Elsayed Akeel MD, et al.
Published: (2022) -
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
by: Jae Won Shin, et al.
Published: (2017) -
Efficacy of levetiracetam for neonatal seizures in preterm infants
by: Ji Yoon Han, et al.
Published: (2018) -
Non-invasive ventilation in neonates: a review of current literature
by: Viraraghavan Vadakkencherry Ramaswamy, et al.
Published: (2023)